Psilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional Investors to Accelerate Clinical Pipeline Focused on DMT

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3dAlIHk
via IFTTT